ERIC BUSSEAR: Open Payments
NPI 1336160258 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 41 payments from 12 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $282 |
| UCB, Inc. | 10 | $159 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Lilly USA, LLC | 3 | $69 |
| PFIZER INC. | 3 | $64 |
| Paratek Pharmaceuticals, Inc. | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $39 |
| GENZYME CORPORATION | 1 | $38 |
| Organon LLC | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
Products named: SKYRIZI, Bimzelx, RINVOQ, COSENTYX, CIBINQO, NUZYRA, TALTZ, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
